{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:57:11Z","timestamp":1793419031089,"version":"4.5.0"},"reference-count":84,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Eukaryotic elongation factor 2 kinase (eEF2K) is a highly unusual protein kinase that negatively regulates the elongation step of protein synthesis. This step uses the vast majority of the large amount of energy and amino acids required for protein synthesis. eEF2K activity is controlled by an array of regulatory inputs, including inhibition by signalling through mammalian target of rapamycin complex 1 (mTORC1). eEF2K is activated under conditions of stress, such as energy depletion or nutrient deprivation, which can arise in poorly-vascularised tumours. In many such stress conditions, eEF2K exerts cytoprotective effects. A growing body of data indicates eEF2K aids the growth of solid tumours in vivo. Since eEF2K is not essential (in mice) under \u2018normal\u2019 conditions, eEF2K may be a useful target in the treatment of solid tumours. However, some reports suggest that eEF2K may actually impair tumorigenesis in some situations. Such a dual role of eEF2K in cancer would be analogous to the situation for other pathways involved in cell metabolism, such as autophagy and mTORC1. Further studies are needed to define the role of eEF2K in different tumour types and at differing stages in tumorigenesis, and to assess its utility as a therapeutic target in oncology.<\/jats:p>","DOI":"10.3390\/cancers9120162","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T11:07:08Z","timestamp":1511780828000},"page":"162","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer"],"prefix":"10.3390","volume":"9","author":[{"given":"Xuemin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-8016","authenticated-orcid":false,"given":"Jianling","family":"Xie","sequence":"additional","affiliation":[{"name":"South Australian Health & Medical Research Institute, North Terrace, Adelaide, SA 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0704-6442","authenticated-orcid":false,"given":"Christopher","family":"Proud","sequence":"additional","affiliation":[{"name":"South Australian Health & Medical Research Institute, North Terrace, Adelaide, SA 5000, Australia"},{"name":"Department of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/aps.2015.123","article-title":"Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases","volume":"37","author":"Liu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbior.2014.04.003","article-title":"Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles","volume":"55","author":"Kenney","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1432-1033.1990.tb19169.x","article-title":"Functional properties of phosphorylated elongation factor 2","volume":"191","author":"Carlberg","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17547","DOI":"10.1074\/jbc.271.29.17547","article-title":"Cloning and expression of cDNA encoding protein synthesis elongation factor-2 kinase","volume":"271","author":"Redpath","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1016\/S0960-9822(99)80006-2","article-title":"Alpha kinases: A new class of protein kinases with a novel catalytic domain","volume":"9","author":"Ryazanov","year":"1999","journal-title":"Curr. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1073\/pnas.94.10.4884","article-title":"Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase","volume":"94","author":"Ryazanov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"ra17","DOI":"10.1126\/scisignal.2000525","article-title":"Crystal structure of the alpha-kinase domain of Dictyostelium myosin heavy chain kinase A","volume":"3","author":"Ye","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1097-2765(01)00256-8","article-title":"Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity","volume":"7","author":"Yamaguchi","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bioorg.2011.08.004","article-title":"The ATP-grasp enzymes","volume":"39","author":"Fawaz","year":"2011","journal-title":"Bioorg. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.1021\/bi0007270","article-title":"Mapping the functional domains of elongation factor-2 kinase","volume":"39","author":"Pavur","year":"2000","journal-title":"Biochemistry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-5793(99)01034-0","article-title":"Analysis of the domain structure of elongation factor-2 kinase by mutagenesis","volume":"457","author":"Diggle","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0300-9084(88)90245-3","article-title":"Phosphorylation of the elongation factor 2: The fifth Ca2+\/calmodulin-dependent system of protein phosphorylation","volume":"70","author":"Ryazanov","year":"1988","journal-title":"Biochimie"},{"key":"ref_13","first-page":"A777","article-title":"Phosphorylation of elongation factor-II by Ca2+ calmodulin-depedent kinase-III","volume":"2","author":"Nairn","year":"1988","journal-title":"FASEB J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cellsig.2006.05.034","article-title":"Sel1-like repeat proteins in signal transduction","volume":"19","author":"Mittl","year":"2007","journal-title":"Cell. Signal."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1021\/acs.biochem.6b00711","article-title":"Structure of the C-Terminal helical repeat domain of eukaryotic elongation factor 2 Kinase","volume":"55","author":"Will","year":"2016","journal-title":"Biochemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BJ20111536","article-title":"Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains","volume":"442","author":"Pigott","year":"2011","journal-title":"Biochem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/BJ20111530","article-title":"Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase","volume":"442","author":"Ruys","year":"2012","journal-title":"Biochem. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1074\/jbc.M110.177014","article-title":"Autophosphorylation activates Dictyostelium myosin II heavy chain kinase A by providing a ligand for an allosteric binding site in the alpha-kinase domain","volume":"286","author":"Crawley","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/MCB.00388-14","article-title":"A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity","volume":"34","author":"Moore","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4161\/auto.29164","article-title":"Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells","volume":"10","author":"Xie","year":"2014","journal-title":"Autophagy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1021\/bi026494p","article-title":"Regulation of elongation factor-2 kinase by Ph","volume":"41","author":"Dorovkov","year":"2002","journal-title":"Biochemistry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/MCB.00012-15","article-title":"Molecular mechanism for the control of eukaryotic elongation factor 2 Kinase by pH: Role in cancer cell survival","volume":"35","author":"Xie","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/MCB.01457-14","article-title":"Elongation factor 2 kinase is regulated by proline hydroxylation and protects cells during hypoxia","volume":"35","author":"Moore","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR Signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1093\/emboj\/20.16.4370","article-title":"Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase","volume":"20","author":"Wang","year":"2001","journal-title":"EMBO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/MCB.01035-14","article-title":"Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling","volume":"34","author":"Wang","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/MCB.24.7.2986-2997.2004","article-title":"A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin","volume":"24","author":"Browne","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/bj20020916","article-title":"Stress-induced regulation of eEF2 kinase by SB203580-sensitive and -insensitive pathways","volume":"367","author":"Knebel","year":"2002","journal-title":"Biochem. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1093\/emboj\/20.16.4360","article-title":"A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4\/p38delta","volume":"20","author":"Knebel","year":"2001","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: A nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0014-5793(02)03582-2","article-title":"ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signalling","volume":"531","author":"McLeod","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.1074\/jbc.M309773200","article-title":"Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398","volume":"279","author":"Browne","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0960-9822(02)01077-1","article-title":"Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis","volume":"12","author":"Horman","year":"2002","journal-title":"Curr. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cellsig.2017.05.010","article-title":"Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase","volume":"36","author":"Johanns","year":"2017","journal-title":"Cell. Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/bies.201400085","article-title":"How does oncogene transformation render tumor cells hypersensitive to nutrient deprivation?","volume":"36","author":"Leprivier","year":"2014","journal-title":"Bioessays"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ccr.2013.05.012","article-title":"Adaptation to starvation: Translating a matter of life or death","volume":"23","author":"Manning","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbagrm.2014.11.002","article-title":"Stress-mediated translational control in cancer cells","volume":"1849","author":"Leprivier","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature13896","article-title":"mTORC1-mediated translational elongation limits intestinal tumour initiation and growth","volume":"517","author":"Faller","year":"2014","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1158\/0008-5472.CAN-10-2889","article-title":"eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206","volume":"71","author":"Cheng","year":"2011","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Li, H., Ren, X., Niu, T., Hait, W.N., and Yang, J. (2010). Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009715"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1158\/0008-5472.CAN-08-2872","article-title":"Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4161\/auto.5.3.7762","article-title":"A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses","volume":"5","author":"Py","year":"2009","journal-title":"Autophagy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1158\/0008-5472.CAN-05-1554","article-title":"Elongation factor-2 kinase regulates autophagy in human glioblastoma cells","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.devcel.2014.01.027","article-title":"Germline quality control: eEF2K stands guard to eliminate defective oocytes","volume":"28","author":"Chu","year":"2014","journal-title":"Dev. Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1128\/MCB.26.10.3955-3965.2006","article-title":"Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells","volume":"26","author":"Connolly","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molcel.2006.01.010","article-title":"Hypoxia-induced energy stress regulates mRNA translation and cell growth","volume":"21","author":"Liu","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/cdd.2017.79","article-title":"MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation","volume":"24","author":"Delaidelli","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2013.04.055","article-title":"The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation","volume":"153","author":"Leprivier","year":"2013","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/bi00356a030","article-title":"Translational control of gene expression in a normal fibroblast. Characterization of a subclass of mRNAs with unusual kinetic properties","volume":"25","author":"Walden","year":"1986","journal-title":"Biochemistry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/72915","article-title":"NMDA-mediated control of protein synthesis at developing synapses","volume":"3","author":"Scheetz","year":"2000","journal-title":"Nat. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jnc.13407","article-title":"eEF2K regulates the synthesis of microtubule-related proteins in neurons","volume":"136","author":"Kenney","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Tekedereli, I., Alpay, S.N., Tavares, C.D., Cobanoglu, Z.E., Kaoud, T.S., Sahin, I., Sood, A.K., Lopez-Berestein, G., Dalby, K.N., and Ozpolat, B. (2012). Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to Doxorubicin in an orthotopic model of breast cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041171"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.18632\/oncotarget.14264","article-title":"MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase","volume":"8","author":"Bayraktar","year":"2017","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbrc.2011.09.038","article-title":"Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression","volume":"414","author":"Zhang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/11109","article-title":"A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection","volume":"1","author":"Holcik","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17148","DOI":"10.1074\/jbc.M308737200","article-title":"Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element","volume":"279","author":"Warnakulasuriyarachchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"29066","DOI":"10.1074\/jbc.M402727200","article-title":"BCL-2 translation is mediated via internal ribosome entry during cell stress","volume":"279","author":"Sherrill","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1074\/jbc.M511319200","article-title":"Internal ribosome entry site-mediated translation of Apaf-1, but not XIAP, is regulated during UV-induced cell death","volume":"281","author":"Ungureanu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ren, L., Zhang, J., Ma, H., Sun, L., Zhang, X., Yu, G., Guan, H., Wang, W., and Li, C. (2016). Synthesis and anti-influenza a virus activity of 6\u2032-amino-6\u2032-deoxy-glucoglycerolipids analogs. Mar. Drugs, 14.","DOI":"10.3390\/md14060116"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4161\/auto.22801","article-title":"Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells","volume":"9","author":"Cheng","year":"2012","journal-title":"Autophagy"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1021\/bi201787p","article-title":"Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: Evidence of a common in vitro artifact","volume":"51","author":"Devkota","year":"2012","journal-title":"Biochemistry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"43951","DOI":"10.1074\/jbc.M111.301291","article-title":"1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): A cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cellsig.2016.01.005","article-title":"Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy","volume":"28","author":"Moore","year":"2016","journal-title":"Cell. Signal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semcdb.2014.08.006","article-title":"mTOR and autophagy: A dynamic relationship governed by nutrients and energy","volume":"36","author":"Dunlop","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1038\/onc.2016.166","article-title":"eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis","volume":"35","author":"Cheng","year":"2016","journal-title":"Oncogene"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.15252\/emmm.201404402","article-title":"Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K","volume":"6","author":"Liu","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.15252\/embr.201642194","article-title":"Pharmacological eEF2K activation promotes cell death and inhibits cancer progression","volume":"17","author":"Demaria","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.cdd.4402296","article-title":"A pharmacoproteomic approach implicates eukaryotic elongation factor 2 kinase in ER stress-induced cell death","volume":"15","author":"Boyce","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/apha.12354","article-title":"Eukaryotic elongation factor 2 kinase controls proliferation and migration of vascular smooth muscle cells","volume":"213","author":"Usui","year":"2015","journal-title":"Acta Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.18632\/oncotarget.7672","article-title":"FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells","volume":"7","author":"Hamurcu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.radonc.2017.04.001","article-title":"eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma","volume":"124","author":"Zhu","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3892\/ol.2015.4072","article-title":"MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma","volume":"11","author":"Shi","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2015.06.017","article-title":"The utilization of extracellular proteins as nutrients is suppressed by mTORC1","volume":"162","author":"Palm","year":"2015","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-5793(94)80121-5","article-title":"Elongation factor-2 kinase: Effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine","volume":"338","author":"Gschwendt","year":"1994","journal-title":"FEBS Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem. J."},{"key":"ref_82","first-page":"6894","article-title":"Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines","volume":"63","author":"Arora","year":"2003","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.bmc.2014.06.050","article-title":"Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors","volume":"22","author":"Edupuganti","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/S0968-0896(02)00160-8","article-title":"TX-1123: An antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity","volume":"10","author":"Hori","year":"2002","journal-title":"Bioorg. Med. Chem."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/9\/12\/162\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:51:26Z","timestamp":1760208686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/9\/12\/162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["cancers9120162"],"URL":"https:\/\/doi.org\/10.3390\/cancers9120162","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}